Recent advances in the management of lung and breast cancer. Future directions

S E Salmon1

  • 1Arizona Cancer Center, University of Arizona College of Medicine, Tucson 85724.

Seminars in Oncology
|August 1, 1990
PubMed

Insights

Future breast cancer treatments may involve novel pharmacologic interventions. These include antisense RNAs to inhibit growth factors or drug resistance, and Her-2-Neu targeted therapies, alongside lifestyle changes with artificial fats.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Breast cancer mortality remains high, necessitating innovative treatment strategies.
  • Understanding cancer biology is crucial for developing effective pharmacologic interventions.
  • Current preventive programs emphasize diet, suggesting lifestyle modifications are key.

Purpose of the Study:

  • To explore novel therapeutic strategies for breast cancer.
  • To investigate the potential of antisense RNAs in cancer treatment.
  • To evaluate targeted therapies and lifestyle interventions for breast cancer.

Main Methods:

  • Exploration of antisense RNA technology to inhibit specific gene expression.
  • Development of monoclonal antibody radioimmunoconjugates targeting the Her-2-Neu oncogene.
  • Consideration of dietary interventions, including artificial fats, for lifestyle modification.

Main Results:

  • Antisense RNAs show promise in inhibiting growth factors and cellular products.
  • Antisense RNAs may overcome drug resistance by inhibiting relevant protein production.
  • Her-2-Neu targeted therapies offer a potential treatment avenue.
  • Artificial fats could aid in adopting healthier, low-fat diets.

Conclusions:

  • Antisense RNA technology presents a promising avenue for breast cancer pharmacologic intervention.
  • Targeting the Her-2-Neu oncogene with radioimmunoconjugates is a viable therapeutic strategy.
  • Dietary modifications, including the use of artificial fats, can support breast cancer prevention efforts.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...